Modern approaches to the treatment of early HPV-associated oropharyngeal cancerAuthors: Fokin H.H. Kravets O.V. Т. 15, №3 (59)
The effect of multiple myeloma therapy on the restoration of renal functionAuthors: Savuliak G.R. Maksymets T.A. Т. 15, №3 (59)
Molecular genetic profile and immunophenotyping of autologous hematopoietic stem cells in multiple myeloma: application of NGS method and monitoring of minimal residual diseaseAuthors: Mygal I.I. Khudziy S.S. Savuliak G.R. Shmygelska S.M.... Т. 15, №3 (59)
Lung oncology: a new era in therapy
Paradigm reset: modern approaches to lung cancer diagnosis and treatmentAuthor:Zviahina O.V. Т. 15, №3 (59)
Analysis of the incidence, diagnosis, and treatment of endometrial carcinosarcoma in patients from 2013 to 2024Authors: Drin I.T. Vytrykhovska I.V. Davydiuk S.S. Kryzhanivska A.Y. Дата: 2025-09-10
Experience of using brentuximab vedotin in combination with chemotherapy for stage IV Hodgkin lymphoma in UkraineAuthors: Kryachok I.A. Titorenko I.B. Moroz Yu.V. Aleksyk O.M.... Т. 15, №2 (58)
KEYTRUDA (pembrolizumab): expanding opportunities in the treatment of resectable non-small cell lung cancerТ. 15, №2 (58)
Anesthetic care of a patient with recessive-dystrophic epidermolysis bullosa: a clinical case and practical recommendationsAuthors: Pochynok O.O. Lisnyy I.I. Ostafiychuk V.V. Т. 15, №2 (58)
Drugs used as radiosensitizers: clinical and pharmaceutical aspects and prospects (literature review)Authors: Andrushchenko I.V. Afanasieva I.O. Т. 15, №2 (58)
Clinical Case of Laparoscopic Simultaneous Resection of the Dorsoventral Segment of the Liver and Transverse Colon ResectionAuthors: Burlaka A. Skyba V. Zemskov S. Mykytyuk A.... Т. 15, №2 (58)
Possibilities of modern visualization methods in planning radiation therapy in patients with cervical cancerAuthors: Ivankova V.S. Domina E.A. Khrulenko T.V. Baranovska L.M.... Т. 15, №2 (58)
Management strategy for gastrointestinal stromal tumors (GIST): current status and future perspectivesAuthors: Kondratskyi Yu.M. Koval N.O. Kolesnyk A.V. Kozak E.O.... Т. 15, №2 (58)
Prognostic factors for successful discontinuation of tyrosine kinase inhibitor treatment in patients with chronic myeloid leukemiaAuthors: Tomashevska N.Y. Kotlyarchuk K.B. Korolchuk O.S. Boyko O.I.... Т. 15, №2 (58)
Modern approaches to the treatment of advanced ovarian cancer in the 1st line therapy (PAOLA-1 study) and recurrent ovarian cancer regardless of the presence of BRCA mutations, as well as modern cytoreductive approaches (based on materials from the ESGO 2025 Congress)
